Literature DB >> 22876598

Solubility enhancement of simvastatin: a review.

Ghulam Murtaza1.   

Abstract

Fairly soluble drugs in gastrointestinal (GI) media exhibit complete oral absorption, and thus good bioavailability. About 40% of drugs are not soluble in water in practice and therefore are slowly absorbed, which results in insufficient and uneven bioavailability and GI toxicity. Thus, most exigent phase of drug development practice particularly for oral dosage forms is the enhancement of drug solubility and thereby its oral bioavailability. Solubility, an important factor to achieve desired plasma level of drug for pharmacological response, is the phenomenon of dissolution of solid in liquid phase resulting in a homogenous system. This review describes various traditional and novel methodologies proposed for solubility enhancement of simvastatin, and ultimately improvement in its bioavailability. For simvastatin, solubility is a crucial rate limiting factor to achieve its desired level in systemic circulation for pharmacological response. Thus, problematic solubility of simvastatin is a main challenge for dosage form developing researchers. Various procedures, illustrated in this review, have been successfully employed to improve the simvastatin solubility for its bioavailability enhancement; however, successful improvement essentially depends on the assortment of technique. Among all the solubility enhancement techniques, solid dispersion method, in terms of ease and efficiency is most promising and routinely employed technique to resolve the solubility problems of simvastatin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22876598

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  14 in total

1.  Population pharmacokinetic analysis of simvastatin and its active metabolite with the characterization of atypical complex absorption kinetics.

Authors:  Seok-Joon Jin; Kyun-Seop Bae; Sang-Heon Cho; Jin-Ah Jung; Unjib Kim; Sangmin Choe; Jong-Lyul Ghim; Yook-Hwan Noh; Hyun-Jung Park; Hee-Sun Kim; Hyeong-Seok Lim
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

2.  Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr-/-Mice.

Authors:  Shamuha Bahetibieke; Sakib M Moinuddin; Asiya Baiyisaiti; Xiaoang Liu; Jie Zhang; Guomin Liu; Qin Shi; Ankang Peng; Jun Tao; Chang Di; Ting Cai; Rong Qi
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

3.  Novel simvastatin inhalation formulation and characterisation.

Authors:  Alaa S Tulbah; Hui Xin Ong; Paolo Colombo; Paul M Young; Daniela Traini
Journal:  AAPS PharmSciTech       Date:  2014-05-08       Impact factor: 3.246

4.  Therapeutic Delivery of Simvastatin Loaded in PLA-PEG Polymersomes Resulted in Amplification of Anti-inflammatory Effects in Activated Microglia.

Authors:  Dharani Manickavasagam; Kimberly Novak; Moses O Oyewumi
Journal:  AAPS J       Date:  2017-12-14       Impact factor: 4.009

5.  Local Application of Statins Significantly Reduced Hypertrophic Scarring in a Rabbit Ear Model.

Authors:  Shengxian Jia; Ping Xie; Seok J Hong; Robert D Galiano; Thomas A Mustoe
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-06-14

6.  Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles.

Authors:  Gabriel Kigen; Geoffrey Edwards
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-04       Impact factor: 2.483

7.  Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs.

Authors:  Vinicius M Alves; Duhyeong Hwang; Eugene Muratov; Marina Sokolsky-Papkov; Ekaterina Varlamova; Natasha Vinod; Chaemin Lim; Carolina H Andrade; Alexander Tropsha; Alexander Kabanov
Journal:  Sci Adv       Date:  2019-06-26       Impact factor: 14.136

8.  Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia.

Authors:  Cecilia Martínez-Jiménez; Jorge Cruz-Angeles; Marcelo Videa; Luz María Martínez
Journal:  Molecules       Date:  2018-08-28       Impact factor: 4.411

9.  Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.

Authors:  Fahad Mehmood Khan; Mahmood Ahmad; Hafiz Arfat Idrees
Journal:  Drug Des Devel Ther       Date:  2020-10-19       Impact factor: 4.162

10.  Preclinical Activity of Simvastatin Induces Cell Cycle Arrest in G1 via Blockade of Cyclin D-Cdk4 Expression in Non-Small Cell Lung Cancer (NSCLC).

Authors:  Yu-Wei Liang; Chi-Chang Chang; Chao-Ming Hung; Tzu-Yu Chen; Tzuu-Yuan Huang; Yi-Chiang Hsu
Journal:  Int J Mol Sci       Date:  2013-03-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.